ADAMTS13 and thrombotic thrombocytopenic purpura: Among the 138 patients in the study cohort, 4 patients (3 survivors and 1 non-survivor) were identified with severe ADAMTS13 deficiency (< 10%), consistent with a diagnosis of TTP (Supplementary Material 1, Supplementary Table 1).